New option listings for May 17th include Correvio Pharma Corporation (CORV), Equinor ASA (ADS) (EQNR), and Sesen Bio Inc (SESN). Option delistings effective May 17th include Cardiome Pharma Corp (CRME), Eleven Biotherapeutics Inc (EBIO), and Statoil ASA (ADS) (STO).
Shell Offshore, a subsidiary of Royal Dutch Shell (RDS.A), announces the final investment decision for Vito, a deep-water development in the U.S. Gulf of Mexico with a forward-looking, break-even price estimated to be less than $35 per barrel. This decision sets in motion the construction and fabrication of a new, simplified host design and subsea infrastructure. Vito is expected to reach peak production of approximately 100,000 barrels of oil equivalent per day, which represents a significant contribution to our continued growth in the Gulf of Mexico. The development currently has an estimated, recoverable resource of 300 million boe. The Vito development is owned by Shell Offshore and Statoil USA E&P (STO); the field is located beneath more than 4,000 feet of water, approximately 150-miles southeast of New Orleans.